EV/EBITDA
13.41
-0.53-3.80%
Wed, 12 Mar 2025 19:09:13 GMT
Summary
- As of March 12, 2025, PTGX EV/EBITDA is 13.41, with a fall of -0.53 (-3.80%) during the most recent trading day.
- Over the past year, PTGX EV/EBITDA has increased by +30.42 (+178.84%).
- PTGX EV/EBITDA is now -27.00% below its all-time high of 18.37.
Performance
PTGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PTGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.8% | -3.8% | -3.8% |
| 1 m1 month | +56.1% | +56.0% | +53.0% |
| 3 m3 months | -10.2% | +50.7% | +42.5% |
| 6 m6 months | -21.9% | +31.0% | +23.2% |
| ytdytd | +51.2% | +51.1% | +48.4% |
| 1 y1 year | +178.8% | +123.2% | +93.8% |
| 5 y5 years | +706.8% | +1961.6% | +757.3% |
PTGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.8% | 8.08 | +66.0% | |
| 3 m | 3-month | 15.58 | -13.9% | 8.08 | +66.0% |
| 6 m | 6-month | 18.37 | -27.0% | 8.08 | +66.0% |
| 1 y | 1-year | 18.37 | -27.0% | -18.03 | +174.4% |
| 3 y | 3-year | 18.37 | -27.0% | -19.12 | +170.1% |
| 5 y | 5-year | 18.37 | -27.0% | -30.57 | +143.9% |
| alltime | all time | 18.37 | -27.0% | -30.57 | +143.9% |
Protagonist Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 13.41(+51.2%) |
| 2024 | 8.87(-170.5%) |
| 2023 | -12.59(+308.8%) |
| 2022 | -3.08(-75.1%) |
| 2021 | -12.37(-1.2%) |
| Date | Value |
|---|---|
| 2020 | -12.52(+435.0%) |
| 2019 | -2.34(+24.5%) |
| 2018 | -1.88(-79.3%) |
| 2017 | -9.10(-15.1%) |
| 2016 | -10.72 |
FAQ
- What is Protagonist Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Protagonist Therapeutics?
- What is PTGX EV/EBITDA year-to-date change?
- What is Protagonist Therapeutics EV/EBITDA year-on-year change?
What is Protagonist Therapeutics EV/EBITDA?
The current EV/EBITDA of PTGX is 13.41
What is the all time high EV/EBITDA for Protagonist Therapeutics?
Protagonist Therapeutics all-time high EV/EBITDA is 18.37
What is PTGX EV/EBITDA year-to-date change?
Protagonist Therapeutics EV/EBITDA has changed by +4.54 (+51.18%) since the beginning of the year
What is Protagonist Therapeutics EV/EBITDA year-on-year change?
Over the past year, PTGX EV/EBITDA has changed by +30.42 (+178.84%)